Evidence map›Paper›PMID 36366308›Full record

ArticleVaccines2022

Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial.

Mohammadreza Ahi, Ramin Hamidi Farahani, Pouria Basiri, Ahmad Karimi Rahjerdi, Ali Sheidaei, Kimiya Gohari, Zahra Rahimi, Fateme Gholami, Milad Moradi, Farzad Ghafoori Naeeni and 7 more

Abstract read
In one paragraph

Article in Vaccines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mohammadreza AhiClinical Trial Center of Iran University of Medical Sciences (IUMS), Tehran P.O. Box 14535, Iran.ORCID 0000-0003-2600-5515
Ramin Hamidi FarahaniAJA University of Medical Sciences, Tehran P.O. Box 1411718541, Iran.
Pouria BasiriStem Cell Technology Research Center (STRC), Tehran P.O. Box 1997775555, Iran.
Ahmad Karimi RahjerdiStem Cell Technology Research Center (STRC), Tehran P.O. Box 1997775555, Iran.ORCID 0000-0001-6017-8482
Ali SheidaeiClinical Trial Center of Iran University of Medical Sciences (IUMS), Tehran P.O. Box 14535, Iran.
Kimiya GohariClinical Trial Center of Iran University of Medical Sciences (IUMS), Tehran P.O. Box 14535, Iran.ORCID 0000-0001-5792-7956
Zahra RahimiClinical Trial Center of Iran University of Medical Sciences (IUMS), Tehran P.O. Box 14535, Iran.
Fateme GholamiClinical Trial Center of Iran University of Medical Sciences (IUMS), Tehran P.O. Box 14535, Iran.ORCID 0000-0001-8829-4864
Milad MoradiStem Cell Technology Research Center (STRC), Tehran P.O. Box 1997775555, Iran.ORCID 0000-0002-2584-458X
Farzad Ghafoori NaeeniStem Cell Technology Research Center (STRC), Tehran P.O. Box 1997775555, Iran.ORCID 0000-0001-7013-327X
Kosar Naderi SaffarStem Cell Technology Research Center (STRC), Tehran P.O. Box 1997775555, Iran.
Soheil GhasemiMilad Daro Noor Pharmaceutical (MDNP) Company, Tehran P.O. Box 1986936914, Iran.
Babak BaratiMilad Daro Noor Pharmaceutical (MDNP) Company, Tehran P.O. Box 1986936914, Iran.
Sohrab MoradiMilad Daro Noor Pharmaceutical (MDNP) Company, Tehran P.O. Box 1986936914, Iran.
Arina MonazahMilad Daro Noor Pharmaceutical (MDNP) Company, Tehran P.O. Box 1986936914, Iran.
Fatemeh PouranvariMilad Daro Noor Pharmaceutical (MDNP) Company, Tehran P.O. Box 1986936914, Iran.
Mohsen ForooghizadehMilad Daro Noor Pharmaceutical (MDNP) Company, Tehran P.O. Box 1986936914, Iran.

Funding

Milad Daro Noor Pharmaceutical (MDNP) Company MDNP
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BBIBP-CorVclinical trialFAKHRAVAC®immunogenicityneutralizing antibody (Nab) and booster-dose injectionsafety

Identifiers

PMID36366308
PMCPMC9695457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.